中国综合临床
中國綜閤臨床
중국종합림상
CLINICAL MEDICINE OF CHINA
2008年
8期
757-759
,共3页
王雷%何明%刘涛%孟宪利%白世祥%平育敏
王雷%何明%劉濤%孟憲利%白世祥%平育敏
왕뢰%하명%류도%맹헌리%백세상%평육민
食管肿瘤%桩蛋白%血管细胞粘附分子%免疫组织化学
食管腫瘤%樁蛋白%血管細胞粘附分子%免疫組織化學
식관종류%장단백%혈관세포점부분자%면역조직화학
Esophageal squamoas cell carcinoma%Paxillin%VCAM-1%Immunohistochemistry
目的 探讨桩蛋白和血管细胞粘附分子(VCAM)-1在食管鳞癌组织中的表达及其与食管鳞癌细胞发生、发展和转移的关系.方法应用免疫组化SP法检测24例正常食管黏膜、94例食管鳞癌组织中VCAM-1和桩蛋白的表达情况.结果桩蛋白表达率与淋巴结转移、浸润深度和临床分期等因素显著相关(P<0.05、P<0.01、P<0.01);VCAM-1与浸润深度、淋巴结转移和临床分期等因素有关(P<0.01、P<0.05、P<0.01).桩蛋白与VCAM-1在癌组织中表达相关(列联r=0.247,P<0.05).结论桩蛋白和VCAM-1在食管鳞癌组织中高表达,可作为评价食管鳞癌生物学行为的指标.
目的 探討樁蛋白和血管細胞粘附分子(VCAM)-1在食管鱗癌組織中的錶達及其與食管鱗癌細胞髮生、髮展和轉移的關繫.方法應用免疫組化SP法檢測24例正常食管黏膜、94例食管鱗癌組織中VCAM-1和樁蛋白的錶達情況.結果樁蛋白錶達率與淋巴結轉移、浸潤深度和臨床分期等因素顯著相關(P<0.05、P<0.01、P<0.01);VCAM-1與浸潤深度、淋巴結轉移和臨床分期等因素有關(P<0.01、P<0.05、P<0.01).樁蛋白與VCAM-1在癌組織中錶達相關(列聯r=0.247,P<0.05).結論樁蛋白和VCAM-1在食管鱗癌組織中高錶達,可作為評價食管鱗癌生物學行為的指標.
목적 탐토장단백화혈관세포점부분자(VCAM)-1재식관린암조직중적표체급기여식관린암세포발생、발전화전이적관계.방법응용면역조화SP법검측24례정상식관점막、94례식관린암조직중VCAM-1화장단백적표체정황.결과장단백표체솔여림파결전이、침윤심도화림상분기등인소현저상관(P<0.05、P<0.01、P<0.01);VCAM-1여침윤심도、림파결전이화림상분기등인소유관(P<0.01、P<0.05、P<0.01).장단백여VCAM-1재암조직중표체상관(렬련r=0.247,P<0.05).결론장단백화VCAM-1재식관린암조직중고표체,가작위평개식관린암생물학행위적지표.
Objective To study the expression of Paxillin and VCAM-1 in esophageal carcinoma and the relationship between the expression of Paxillin, VCAM-1 and carcinogenesis and progression of esophageal carcinoma. Methods Paxillln and VCAM-1 expression were detected in 24 normal esophageal mucosa and 94 primary tumor tissues with SP immunohistochemistal method. Results The expression rate of PaxiUin was related to invasive depth (P <0.01) ,clinical staging (P <0.01) and metastasis of lymph node (P <0.05). The expression rate of VCAM-1 was related to invasive depth (P < 0.01) ,clinical staging (P < 0.01) and metastasis of lymph node (P<0.05). There was a positive correlation between Paxillin and VCAM-1 expression in this study (r = 0. 247 ,P < 0.05). Conlusion Paxillin and VCAM-1 are over expressed in esophageal carcinoma. They can be used as valuable biomakers to evaluate biological characteristics in esophageal carcinoma.